HIGHLIGHTS
- who: Kleanthis Fytianos et al. from the Department of Pulmonary Medicine, University Hospital Bern, Bern, Switzerland have published the research: Anti-Fibrotic Effect of SDF-1 Overexpression in Bleomycin-Injured Rat Lung, in the Journal: Pharmaceutics 2022, 1803 of 29/07/2022
- what: The authors investigate the effect of overexpression of SDF-1u03b2 on structure using the model. The study demonstrates a new antifibrotic mechanism of SDF-1u03b2 overexpression and suggests SDF-1u03b2 as a potential new approach for the treatment of fibrosis. The authors observed increased TNF-u03b1 levels in response to SDF-1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.